Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy

Urology

Volumn 50, Issue 5, 1997, Pages 727-732

  Chun, Thomas Y ^a,b   Martin, Sheila ^a   Lepor, Herbert ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CANCER SURGERY; CLINICAL TRIAL; HUMAN; INJECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; COSTS AND COST ANALYSIS; ERYTHROPOIETIN, RECOMBINANT; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSTATECTOMY;

EID: 0030665367     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00481-0     Document Type: Article

References (16)

1. Toy PT, Menozzi D, Strauss RG, Stehling LC, Kruskall M, and Ahn DK: Efficacy of preoperative donation of blood for autologous use in radical prostatectomy. Transfusion 33: 721-724, 1993.
2. Yamada AH, Lieskovsky G, Skinner DG, Shulman I, Groshen S, and Chen SC: Impact of autologous blood transfusions on patients undergoing radical prostatectomy using hypotensive anesthesia. J Urol 149: 73-76, 1993.
3. Goodnough LT, Riddell J IV, Kursh E, and Resnick MI: Utilization and efficacy of autologous blood predeposit in radical prostatectomy with lymphadenectomy: implications for blood conservation and physician education programs. Urology 40: 201-205, 1992.
4. Peters CA, and Walsh PC: Blood transfusion and anesthetic practices in radical retropubic prostatectomy. J Urol 134: 81-83, 1985.
5. Faris PM, Ritter MA, and Abels RI: The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation: the American Erythropoietin Study Group. J Bone Joint Surg Am 78-A: 62-72, 1996.
6. de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, and Young DC: Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 25: 533-542, 1996.
7. Goldberg MA, McCutchen JW, Jove M, Di Cesare P, Friedman RJ, Poss R, Guilfoyle M, Frei D, and Young D: A safety and efficacy comparison study of two dosing regimens of Epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 25: 544-552, 1996.
8. Canadian Orthopedic Perioperative Erythropoietin Study Group: Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 341: 1227-1232, 1993.
9. Monk TG, Goodnough LT, Andriole GL, Colberg JW, Catalona WJ, and Martin KJ: Preoperative recombinant human erythropoietin therapy improves outcome with acute normovolemic hemodilution (abstract). Blood 84: 466a, 1994.
10. Adamson JW, and Spivak JL: Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment. Surgery 115: 7-15, 1994.
11. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, and Spivak JL: Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322: 1689-1692, 1990.
12. Koch MO, and Smith JA Jr: Blood loss during radical retropubic prostatectomy: is preoperative autologous blood donation indicated? J Urol 156: 1077-1080, 1996.
13. Goh M, Kleer LG, Kielczewski P, Wojnok J, Kim K, and Oesterling JE: Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary? Urology 49: 569-574, 1997.
14. Kannel WB, Gordon T, Wolf PA, and McNamara P: Hemoglobin and the risk of cerebral infarction: the Framingham Study. Stroke 3: 409-420, 1972.
15. Wannamethee G, Perry IJ, and Shaper AG: Haematocrit, hypertension and risk of stroke. J Intern Med 235: 163-168, 1994.
16. Erikssen G, Thaulow E, Sandvik L, Stormorken H, and Erikssen J: Haematocrit: a predictor of cardiovascular mortality? J Intern Med 234: 493-499, 1993.